Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisArun J. Sanyal, Patricia R. Robuck, Naga Chalasani et al.|New England Journal of Medicine|2010Cited by 3.3k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trialBrent A. Neuschwander‐Tetri, Edward Doo, Manal F. Abdelmalek et al.|The Lancet|2014Cited by 2.2k
Nonalcoholic fatty liver diseaseElizabeth M. Brunt, Mary E. Rinella|Nature Reviews Disease Primers|2015Cited by 832
Endpoints and clinical trial design for nonalcoholic steatohepatitisArun J. Sanyal, Arthur J. McCullough, Elizabeth M. Brunt et al.|Hepatology|2011Cited by 757
AAV Vector Integration Sites in Mouse Hepatocellular CarcinomaAnthony Donsante, Mark S. Sands, Daniel G. Miller et al.|Science|2007Cited by 648